These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69. Complex evolution and epidemiology of Dobrava-Belgrade hantavirus: definition of genotypes and their characteristics. Klempa B; Avsic-Zupanc T; Clement J; Dzagurova TK; Henttonen H; Heyman P; Jakab F; Kruger DH; Maes P; Papa A; Tkachenko EA; Ulrich RG; Vapalahti O; Vaheri A Arch Virol; 2013 Mar; 158(3):521-9. PubMed ID: 23090188 [TBL] [Abstract][Full Text] [Related]
70. A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters. Vergote V; Laenen L; Vanmechelen B; Van Ranst M; Verbeken E; Hooper JW; Maes P PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006042. PubMed ID: 29077702 [TBL] [Abstract][Full Text] [Related]
71. Global Comprehensive Outlook of Hantavirus Contagion on Humans: A Review. Ashique S; Sandhu NK; Das S; Haque SN; Koley K Infect Disord Drug Targets; 2022; 22(3):e050122199975. PubMed ID: 34986775 [TBL] [Abstract][Full Text] [Related]
72. Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus-associated syndromes. Klingström J; Smed-Sörensen A; Maleki KT; Solà-Riera C; Ahlm C; Björkström NK; Ljunggren HG J Intern Med; 2019 May; 285(5):510-523. PubMed ID: 30663801 [TBL] [Abstract][Full Text] [Related]
73. Hantavirus: an increasing problem? Hart CA; Bennett M Ann Trop Med Parasitol; 1994 Aug; 88(4):347-58. PubMed ID: 7979621 [TBL] [Abstract][Full Text] [Related]
74. Immune response during hantavirus diseases: implications for immunotherapies and vaccine design. Saavedra F; Díaz FE; Retamal-Díaz A; Covián C; González PA; Kalergis AM Immunology; 2021 Jul; 163(3):262-277. PubMed ID: 33638192 [TBL] [Abstract][Full Text] [Related]
75. [Hantaviruses]. Ferreira MS Rev Soc Bras Med Trop; 2003; 36(1):81-96. PubMed ID: 12715067 [TBL] [Abstract][Full Text] [Related]
76. Emergence and persistence of hantaviruses. Klein SL; Calisher CH Curr Top Microbiol Immunol; 2007; 315():217-52. PubMed ID: 17848067 [TBL] [Abstract][Full Text] [Related]
77. Dentin matrix protein 1 correlates with the severity of hemorrhagic fever with renal syndrome and promotes hyper-permeability of endothelial cells infected by Hantaan virus. Shi D; Dong Y; Dai P; Gao J; Yin J; Xie M Microbes Infect; 2019; 21(7):321-327. PubMed ID: 30735719 [TBL] [Abstract][Full Text] [Related]
78. Emerging hantaviruses in Central Argentina: First case of Hantavirus Pulmonary Syndrome caused by Alto Paraguay virus, and a novel orthohantavirus in Scapteromys aquaticus rodent. Bellomo C; Alonso DO; Ricardo T; Coelho R; Kehl S; Periolo N; Azogaray V; Casas N; Ottonelli M; Bergero LC; Cudós MC; Previtali MA; Martinez VP PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009842. PubMed ID: 34788281 [TBL] [Abstract][Full Text] [Related]
79. Puumala and Tula Virus Differ in Replication Kinetics and Innate Immune Stimulation in Human Endothelial Cells and Macrophages. Bourquain D; Bodenstein C; Schürer S; Schaade L Viruses; 2019 Sep; 11(9):. PubMed ID: 31540120 [TBL] [Abstract][Full Text] [Related]
80. Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability. Pepini T; Gorbunova EE; Gavrilovskaya IN; Mackow JE; Mackow ER J Virol; 2010 Nov; 84(22):11929-36. PubMed ID: 20844033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]